Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Dorina Kotoni

Dorina Kotoni

Dorina Kotoni is Analytical Expert and Principal Scientist at Novartis, Basel, Switzerland. After gaining an MS in Pharmaceutical Chemistry, Dorina completed her PhD in Pharmaceutical Sciences at the Sapienza University of Rome. First as a PhD student and later as a Post-Doc Fellow in Prof. Gasparrini ’s lab, Dorina’s research focused on the preparation and characterization of chiral stationary phases for enantioselective UHPLC and UHPSFC, as well as on the development of new HILIC materials for rapid speed analysis of carbohydrates. Her interest in both chiral and achiral UHPLC columns, has l ed to a more in-depth study of the parameters influencing chromatographic performance in UHPLC. Dorina is currently working in Novartis with a focus on the HPLC to UHPLC transition and HIL IC method development.

  • Contributions

The Search for the Ideal Detector

April 25, 2016

Will aerosol-based detectors ever meet all the needs of the pharmaceutical industry?

1 min read

The Search for the Ideal Detector

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.